You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Clinical applications of PD-1-based therapy: a focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types
|
---|---|
Published in |
OncoTargets and therapy, April 2015
|
DOI | 10.2147/ott.s53164 |
Pubmed ID | |
Authors |
Tara C Gangadhar, April KS Salama |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Denmark | 1 | 1% |
Korea, Republic of | 1 | 1% |
Belgium | 1 | 1% |
Unknown | 64 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 16% |
Student > Bachelor | 10 | 15% |
Student > Ph. D. Student | 10 | 15% |
Student > Master | 9 | 13% |
Other | 5 | 7% |
Other | 11 | 16% |
Unknown | 11 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 23 | 34% |
Agricultural and Biological Sciences | 11 | 16% |
Biochemistry, Genetics and Molecular Biology | 9 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Immunology and Microbiology | 2 | 3% |
Other | 6 | 9% |
Unknown | 14 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2022.
All research outputs
#2,655,949
of 25,374,917 outputs
Outputs from OncoTargets and therapy
#73
of 3,016 outputs
Outputs of similar age
#33,423
of 279,166 outputs
Outputs of similar age from OncoTargets and therapy
#2
of 37 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,166 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.